• Marijuana Unusual Option Activity Weekly Stock Options Alerts

Stock-Options-Picks.com has found a strategy that is very effective for Unusual Option Activity


Marijuana Unusual Option Activity Weekly Stock Options Alerts

Weekly Unusual Activity Stock Options Alerts

We provide option strategy analysis and research market data, managed by group of professional Stock Market Traders..


Top Marijuana Stocks on the NASDAQ

We provide option strategy analysis and research market data, managed by group of professional Stock Market Traders..

Increase your income trade marijuana stocks options picks

 

The NASDAQ was the first electronic exchange and has long been synonymous with technology and biotechnology.

The cannabis companies on the NASDAQ reflect this, with the majority of them operating in the biotech area of the industry.

Here are the NASDAQ-listed marijuana stocks, in alphabetical order,  with a breakdown of their total returns.

 

Past Performance

 

We started our service in 2012


Make Money Whether Market Moves:

Consistent, Low-Risk Income Strategy

 

High return with Calls and Puts UP 100 % to 1000% in One week

 

Up

Sideways

Down (Even Crashes)

 

 

Tilray Inc. (NASDAQ: TLRY)

Tilray Inc. was the first marijuana-related company to IPO in the U.S. The Nanaimo, Vancouver Island-based company focuses on medical cannabis products.

 

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is a biotech company involved in the manufacturing of medical marijuana drugs. Research and development around Arena's APD371 is the primary focus of its cannabis biotech initiatives.


 

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities for the indications of pain and pruritus (itching). Although all of their clinical-stage products target opioid receptors, Cara is currently conducting preclinical research on cannabinoids for the treatment of neuropathic pain.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech company. Its research, development, and manufacturing are based around cannabis drugs that seek to treat chronic, inflammatory, fibrotic and other diseases.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is a Canadian cannabis company. It owns and seeks cannabis related subsidiaries and licensed producers. In December of 2018, Marlboro maker Altria announced plans to invest $1.8 billion in Cronos. The investment has provided Cronos not only with additional cash to finance its continued expansion, but also with a well-established partner experienced in the process of marketing consumer brands.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is developing a portfolio of cannabinoid medicines, including Sativex for the treatment of spasticity related to multiple sclerosis and cancer pain, and Epidiolex for the treatment of childhood epilepsy. Sativex is commercialized in more than a dozen countries outside the U.S. and has received regulatory approval in several more countries. Epidiolex received FDA approval as a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two forms of severe, early onset epilepsy without good existing treatment options. Other indications show that GW Pharmaceuticals is developing cannabinoid products for autism spectrum disorders, schizophrenia and glioma.

Insys Therapeutics Inc. (NASDAQ:INSY)

Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems. Though the company is more widely known for its Subsys fentanyl spray, Insys has received FDA approval for a dronabinol (synthetic THC) oral solution for the treatment of nausea caused by chemotherapy and anorexia in patients with AIDS. Insys is also developing cannabinoid-based treatments for epileptic disorders, Prader-Willi Syndrome (a genetic disorder) and amphetamine addiction among other indications.

 

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is a clinical-stage biopharmaceutical company that is developing drugs based on its proprietary Accordion Pill technology. Intec's product pipeline includes cannabinoid-based drugs being developed for the indications of low back pain and fibromyalgia.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation operates in the enforcement sector. Its business operations support drug testing through hair samples.

 

Village Farms International (NASDAQ: VFF)

Village Farms International is the most recent cannabis stock to begin trading on the NASDAQ. VFF shares became available for trade on February 21, 2019. The company has a decades-long history in greenhouse produce growing and has only recently shifted some of its focus toward cannabis production.

Control Your Risk, Trade with Certainty

Short-term trading offers the best of both worlds. You can make short, fast, exciting trades combined with knowing your maximum profit or loss BEFORE you trade.

Stock Options Picks  trading weekly options.

You’ll not only learn how we trade weekly options,

You will also learn a way to increase  probabilities to your advantage.

We started our service in 2012


Make Money Whether Market Moves:

Consistent, Low-Risk Income Strategy

 

High return with Calls and Puts UP 100 % to 1000% in One week

 

Up

Sideways

Down (Even Crashes)


Past Performance

+ 500% many more

 

 

If you are interested in increasing  your income over the next year.

Please sign up for our 

 Stock Options Picks Alerts  1 Year

Subscribe Now

.

You’ll not only learn how we trade options,

You will also learn a way to increase  probabilities to your advantage.

Marijuana Unusual Option Activity Weekly Stock Options Alerts

  • Product Code: Marijuana Unusual Option Activity Weekly Stock Options Alerts
  • Availability: 1000
  • $599.99


Tags: Earnings Unusual Activity Stock Options Alerts